March 26 (Reuters) - Shield AI is raising $2 billion in a new funding round at a $12.7 billion valuation, as the defense technology startup looks to expand its artificial intelligence-powered software ...

The March 7 Shield of the Americas Summit sent a message that matters: The Western Hemisphere is not a recurring crisis to “manage” and then move on. Rather, the Americas are central to U.S. foreign ...

The company, which develops autonomous military technology, also plans to buy a maker of simulation software as interest in next-generation defense soars. By Michael J. de la Merced Artificial ...

CAMP HUMPHREYS, South Korea — The United States and South Korea have wrapped up a major joint exercise focused on preparing Seoul to assume wartime operational control of allied forces. The 10-day ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield™ multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in ...

Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines Eligible Manulife customers in Hong Kong ...

PALO ALTO, Calif. & HONG KONG--(BUSINESS WIRE)--Mar 16, 2026-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield™ multi-cancer ...

HONG KONG, SINGAPORE, and MANILA, Philippines, March 16, 2026 /PRNewswire/ — Manulife today announced an exclusive partnership with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

First insurer in Asia to bring the innovative blood-based multi‑cancer screening solution to Hong Kong, Singapore, and the Philippines HONG KONG, SINGAPORE, and MANILA, Philippines, March 16, 2026 ...